Thursday, April 10, 2014

An FDA warning letter often means a tipping point has been reached

Every week there is some news, recall or event that reminds us that the give and take with the FDA over manufacturing often means poor GMPs give companies major headaches and take a lot of time and money to resolve.
A week ago, it was Johnson & Johnson ($JNJ) recalling nearly 70,000 packages of its K-Y Liquibeads Vaginal Moisturizer. This week it is an item on how Extra Strength Excedrin will cost you up to $100 a bottle on eBay. Extra Strength Excedrin is one of Novartis' ($NVS) many OTC products that are in short supply since closing a plant in Lincoln, NE, for remediation


Read more: An FDA warning letter often means a tipping point has been reached - FiercePharma Manufacturing http://www.fiercepharmamanufacturing.com/story/fda-warning-letter-often-means-tipping-point-has-been-reached/2012-07-09#ixzz2yUqXjngV
Subscribe at FiercePharma Manufacturing

No comments: